Key result
Activation of Kv7.5 by flupirtine attenuated cell proliferation by arresting cells in the G0/G1 phase in canine osteosarcoma cells.
Kv7.5 activation by flupirtine exerts an anti-proliferative effect in canine osteosarcoma cells, highlighting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Kv7.5 activation in osteosarcoma; leaves open translation beyond canine cell lines.
The KCNQ gene family, whose members encode Kv7 channels, belongs to the voltage-gated potassium (Kv) channel group. The roles of this gene family have been widely investigated in nerve and muscle cells. In the present study, we investigated several characteristics of Kv7.5, which is strongly expressed in the canine osteosarcoma cell line, CCL-183. Serum starvation upregulated Kv7.5 expression, and the Kv7 channel opener, flupirtine, attenuated cell proliferation by arresting cells in the G0/G1 phase. We also showed that Kv7.5 knockdown helps CCL-183 cells to proliferate. In an effort to find an endogenous regulator of Kv7.5, we used mithramycin A to reduce the level of the transcription factor Sp1, and it strongly inhibited the induction of Kv7.5 in CCL-183 cells. These results suggest that the activation of Kv7.5 by flupirtine may exert an anti-proliferative effect in canine osteosarcoma. Therefore, Kv7.5 is a possible molecular target for canine osteosarcoma therapy.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2014) studied Canine osteosarcoma. Flupirtine was evaluated on Cell proliferation. Activation of Kv7.5 by flupirtine attenuated cell proliferation by arresting cells in the G0/G1 phase in canine osteosarcoma cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: